IN THE NEWS
December 18, 2024
Cedars-Sinai secures research funding to develop eye transplantation procedures to cure blindness
Cedars-Sinai
Cedars-Sinai to explore innovative surgical treatment options meant to restore vision for patients with total blindness
Cedars-Sinai has secured funding from the government for research aimed at pioneering new surgical approaches to cure total blindness through whole eye transplantation. Cedars joins several other prominent centers in this research. Their work will focus on developing protocols for the procurement and preservation of donor tissue as well as the eye transplant surgeries themselves.
As the first institution on the West Coast to have microsurgical robotic capabilities and a leader in novel approaches to treating eye diseases, Cedars Sinai will utilize the Symani Surgical System as part of their research efforts.
Read more to learn about the research grant and Cedar-Sinai's role
MMI is not affiliated with or partnering with Cedars-Sinai on ophthalmic research. This article is for informational purposes only and does not imply collaboration or endorsement between MMI and Cedars-Sinai.
The Symani Surgical System is not currently indicated for use in ophthalmic procedures. Approved clinical indications vary by geography. Refer to global indications for more information.
Related News
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Wins FDA Clearance and Completes First U.S. Clinical Use of Robotic Microsurgical Dissection Instruments with Symani
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
MMI Announces CPT Code and CMS Reimbursement for Robotic Lymphatic Surgery, Unlocking Market Access and Growth Potential
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
Leading New Jersey hospital treats first patient with new robotic surgical approach to manage symptoms of breast-cancer related lymphedema
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Receives IDE Approval from FDA for First Robotic Microsurgical Study in Alzheimer’s Patients
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Enrolls First Patient in Landmark U.S. Clinical Study Advancing Robotic Microsurgery
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
MMI Completes World’s First Robotic Microsurgical Intracranial Brain Surgery
MMI CEO Mark Toland on How the Symani Surgical System Is Redefining Robotic Microsurgery
MMI CEO Mark Toland on How the Symani Surgical System Is Redefining Robotic Microsurgery
World-first robotic throat surgery at Melbourne hospital saves patient’s voice and ability to eat
World-first robotic throat surgery at Melbourne hospital saves patient’s voice and ability to eat
MMI’s Symani® System Redefines Robotic Microsurgery Again with First-Ever Dissection and Digital Surgery Capabilities
MMI’s Symani® System Redefines Robotic Microsurgery Again with First-Ever Dissection and Digital Surgery Capabilities
MMI to Present at 43rd Annual J.P. Morgan Healthcare Conference
MMI to Present at 43rd Annual J.P. Morgan Healthcare Conference
Cedars-Sinai secures research funding to develop eye transplantation procedures to cure blindness
Cedars-Sinai secures research funding to develop eye transplantation procedures to cure blindness
St. Vincent’s Hospital in Melbourne is first health system in Australia to adopt robotic-assisted microsurgery with Symani
